RAC 2.92% $1.94 race oncology ltd

General Comments / Chat, page-7519

  1. 417 Posts.
    lightbulb Created with Sketch. 66
    It's looking like by the time this stock does anything CAR-T will be dominating the oncology sector and zantrene will become obsolete
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.